PHARMACODYNAMICS OF PROPYLTHIOURACIL IN NORMAL AND HYPERTHYROID SUBJECTS AFTER A SINGLE ORAL DOSE

被引:34
作者
MCMURRY, JF
GILLILAND, PF
RATLIFF, CR
BOURLAND, PD
机构
[1] SCOTT & WHITE CLIN, SECT ENDOCRINOL, TEMPLE, TX 76501 USA
[2] SCOTT & WHITE CLIN, SECT CLIN CHEM, TEMPLE, TX 76501 USA
[3] SCOTT & WHITE CLIN, SECT BIOPHYS, TEMPLE, TX 76501 USA
关键词
D O I
10.1210/jcem-41-2-362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:362 / 364
页数:3
相关论文
共 6 条
[1]   METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].
ALEXANDER, WD ;
EVANS, V ;
MACAULAY, A ;
GALLAGHER, TF ;
LONDONO, J .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+
[2]  
ASTWOOD EB, 1970, PHARMACOL BASIS, P1487
[3]   ACCUMULATION OF S-35-ANTITHYROID DRUGS BY THYROID-GLAND [J].
MARCHANT, B ;
LAZARUS, JH ;
ALEXANDER, WD ;
CLARK, DH ;
LEES, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 34 (05) :847-+
[4]  
RATLIFF CR, 1972, CLIN CHEM, V18, P1373
[5]   PHARMACOKINETICS OF PROPYLTHIOURACIL IN MAN AFTER A SINGLE ORAL DOSE [J].
SITAR, DS ;
HUNNINGHAKE, DB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (01) :26-29
[6]  
WINE RL, 1964, STATISTICS SCIENTIST, P492